XML 15 R46.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Reporting (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2015
USD ($)
Mail_Service_Pharmacy
state
drugstore
pharmacy
Sep. 30, 2014
USD ($)
Sep. 30, 2015
USD ($)
Mail_Service_Pharmacy
state
drugstore
segment
pharmacy
Sep. 30, 2014
USD ($)
Segment reporting information        
Number of segments | segment     3  
Net revenues $ 38,644 $ 35,021 $ 112,144 $ 102,312
Gross profit 6,661 6,468 19,227 18,734
Operating profit (loss)(3) $ 2,331 2,246 $ 6,725 6,478
Pharmacy Services Segment        
Segment reporting information        
Number of Centers of Excellence for Infusion and Enteral Services 6   6  
Number of states pharmacies operated | state 40   40  
Net revenues [1] $ 25,528 22,534 $ 73,849 64,566
Gross profit 1,468 1,403 3,735 3,533
Operating profit (loss)(3) 1,162 1,087 2,837 2,605
Net revenues, retail co-payments $ 2,100 1,900 $ 6,800 6,100
Pharmacy Services Segment | Specialty stores        
Segment reporting information        
Number of pharmacies | pharmacy 24   24  
Pharmacy Services Segment | Specialty mail order        
Segment reporting information        
Number of pharmacies | pharmacy 11   11  
Pharmacy Services Segment | Mail service        
Segment reporting information        
Number of pharmacies | Mail_Service_Pharmacy 5   5  
Pharmacy Services Segment | Infusion and Enteral Branches        
Segment reporting information        
Number of Infusion and Enteral Branches | Mail_Service_Pharmacy 83   83  
Pharmacy Services Segment | Ambulatory infusion suites [Member]        
Segment reporting information        
Number of Infusion and Enteral Branches | Mail_Service_Pharmacy 73   73  
Retail/LTC Segment [Member]        
Segment reporting information        
Number of states pharmacies operated | state 44   44  
Number of retail drugstores | drugstore 7,911   7,911  
Net revenues $ 17,912 16,749 $ 52,105 50,100
Gross profit 5,373 5,237 15,990 15,719
Operating profit (loss)(3) $ 1,643 1,527 $ 5,050 4,982
Number of retail drugstores operating a pharmacy | drugstore 7,852   7,852  
Number of LTC spoke pharmacies | drugstore 113   113  
Number of LTC hub pharmacies | drugstore 32   32  
Retail/LTC Segment [Member] | MinuteClinic within CVS Pharmacy Stores        
Segment reporting information        
Number of clinics in retail drugstores | drugstore 1,013   1,013  
Retail/LTC Segment [Member] | MinuteClinic        
Segment reporting information        
Number of clinics | drugstore 1,020   1,020  
Retail/LTC Segment [Member] | Specialty stores        
Segment reporting information        
Number of pharmacies | drugstore 33   33  
Intersegment Eliminations        
Segment reporting information        
Net revenues [2] $ (4,796) (4,262) $ (13,810) (12,354)
Gross profit [2] (180) (172) (498) (518)
Operating profit (loss)(3) [2],[3] (165) (172) (450) (518)
Corporate Segment        
Segment reporting information        
Net revenues 0 0 0 0
Gross profit 0 0 0 0
Operating profit (loss)(3) (309) $ (196) (712) $ (591)
Business acquisition transaction costs $ 115   $ 135  
[1] Net revenues of the Pharmacy Services Segment include approximately $2.1 billion and $1.9 billion of retail co-payments for the three months ended September 30, 2015 and 2014, respectively, as well as $6.8 billion and $6.1 billion of retail co-payments for the nine months ended September 30, 2015 and 2014, respectively.
[2] Intersegment eliminations relate to intersegment revenue generating activities that occur between the Pharmacy Services Segment and the Retail/LTC Segment. These occur in the following ways: when members of Pharmacy Services Segment clients (“members”) fill prescriptions at retail stores to purchase covered products, when members enrolled in programs such as Maintenance Choice® elect to pick up maintenance prescriptions at a retail drugstore instead of receiving them through the mail, or when members have prescriptions filled at long-term care facilities. When these occur, both the Pharmacy Services and Retail/LTC segments record the revenues, gross profit and operating profit on a standalone basis.
[3] The Corporate Segment operating loss includes $115 million and $135 million of acquisition-related transaction and integration costs for the three and nine months ended September 30, 2015, respectively.